Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-001 - Depth of Target Lesion Response to Brigatinib and Its Association With Outcomes in Patients With ALK+ NSCLC in the ALTA Trial
09:30 - 09:30 | Presenter: D. Ross Camidge | Author(s): M. Tiseo, Myung-Ju Ahn, Karen L Reckamp, K.H. Hansen, Sang-We Kim, Rudolf M Huber, Howard L West, H.J. Groen, Maximilian Johannes Hochmair, Natasha B Leighl, Scott N. Gettinger, Corey J Langer, Luis Paz-Ares, Egbert F Smit, E.S. Kim, W. Reichmann, D. Kerstein, D. Kim
- Abstract
Loading... -
+
P1.01-070 - BIW-8962, an Anti-GM2 Ganglioside Monoclonal Antibody, in Advanced/Recurrent Lung Cancer: A Phase I/II Study
09:30 - 09:30 | Presenter: Joo-Hang Kim | Author(s): J. Lee, Sang-We Kim, Jin-Hyoung Kang, Dae Ho Lee, Byoung Chul Cho, N. Shiraishi, V. Strout, Keunchil Park
- Abstract
Loading...
-
+
P1.15 - SCLC/Neuroendocrine Tumors
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: SCLC/Neuroendocrine Tumors
-
+
P1.15-004 - An Open-Label, Multitumor Phase II Basket Study of Olaparib and Durvalumab (MEDIOLA): Results in Patients with Relapsed SCLC
09:30 - 09:30 | Presenter: Matthew G Krebs | Author(s): K. Ross, Sang-We Kim, M. De Jonge, Fabrice Barlesi, S. Postel-Vinay, S.M. Domchek, J. Lee, H.K. Angell, K. Bui, S. Chang, C. Gresty, P. Herbolsheimer, J. Delord
- Abstract
Loading...
-
+
MS 07 - Neuroendocrine Tumors other than SCLC: Pathology to Patient Management
- 15:45 - 17:30
- 10/16/2017
- Location: F203 + F204 (Annex Hall)
- Type: Mini Symposium
- Track: SCLC/Neuroendocrine Tumors
- Moderators:C. Barrios, Sang-We Kim
-
+
MS 07.01 - Pathology of Neuroendocrine Tumors other than SCLC
15:45 - 16:00 | Presenter: Mary Beth Beasley
- Abstract
Loading... -
+
MS 07.02 - Novel Chemotherapy for LCNEC
16:00 - 16:15 | Presenter: Seiji Niho
- Abstract
Loading... -
+
MS 07.03 - Novel Systemic Therapy for Carcinoid of the Lung
16:15 - 16:30 | Presenter: Primo Lara
- Abstract
Loading... -
+
MS 07.04 - Surgical Treatment for Neuroendocrine Tumors other than SCLC
16:30 - 16:45 | Presenter: Akira Iyoda | Author(s): Yoko Azuma, T. Makino, H. Otsuka, S. Koezuka, N. Tochigi, K. Shibuya, T. Mikami, Kazutoshi Isobe, S. Homma
- Abstract
Loading... -
+
MS 07.05 - ESTS Registration for Neuroendocrine Tumors
16:45 - 17:00 | Presenter: Pier Luigi Filosso | Author(s): F. Guerrera, P. Lyberis, E.L.N.S. Committee
- Abstract
Loading... -
+
MS 07.06 - Which Chemotherapy or Targeted Therapy is Better for Treatment of LCNEC Patients: SCLC-based versus Non-SCLC-based Regimens?
17:00 - 17:15 | Presenter: Sumitra Thongprasert
- Abstract
Loading... -
+
MS 07.07 - Q&A
17:15 - 17:30
- Abstract
No abstract available for this presentation
-
+
OA 05 - Next Generation TKI
- 15:45 - 17:30
- 10/16/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:James Chih-Hsin Yang, Fiona Blackhall
-
+
OA 05.03 - Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients with EGFR Activating and T790M Mutations
16:05 - 16:15 | Presenter: Keunchil Park | Author(s): K. Azuma, C. Tsai, Takashi Seto, H. Nokihara, James Chih-Hsin Yang, Sang-We Kim, H. Murakami, Makoto Nishio, K. Kiura, A. Inoue, K. Takeda, Jin-Hyoung Kang, Hidetoshi Hayashi, T. Nakagawa, Y. Kaneko, R. Akazawa, M. Shimazaki, S. Morita, M. Fukuoka, Kazuhiko Nakagawa
- Abstract
Loading... -
+
OA 05.05 - Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Updated Efficacy and Safety Results From ALTA, a Randomized Phase 2 Trial
16:30 - 16:40 | Presenter: Myung-Ju Ahn | Author(s): D. Ross Camidge, M. Tiseo, Karen L Reckamp, K.H. Hansen, Sang-We Kim, Rudolf M Huber, Howard L West, H.J. Groen, Maximilian Johannes Hochmair, Natasha B Leighl, Scott N. Gettinger, Corey J Langer, Luis Paz-Ares, Egbert F Smit, E.S. Kim, W. Reichmann, D. Kerstein, D. Kim
- Abstract
Loading... -
+
OA 05.07 - Efficacy and Updated Safety of Ceritinib (450 Mg or 600 Mg) with Low-Fat Meal vs 750 Mg Fasted in ALK+ Metastatic NSCLC
16:50 - 17:00 | Presenter: Byoung Chul Cho | Author(s): R. Obermannová, A. Bearz, D. Kim, S. Orlov, G. Borra, Sang-We Kim, Pieter E. Postmus, S.A. Laurie, Keunchil Park, S.L. Geater, A.C. Bettini, K. Osborne, V.Q. Passos, Z. Chen, Rafal Dziadziuszko
- Abstract
Loading...
-
+
OA 09 - EGFR TKI Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:Thanyanan Reungwetwattana, Lecia V Sequist
-
+
OA 09.03 - TATTON Ph Ib Expansion Cohort: Osimertinib plus Savolitinib for Pts with EGFR-Mutant MET-Amplified NSCLC after Progression on Prior EGFR-TKI
11:20 - 11:30 | Presenter: Myung-Ju Ahn | Author(s): Ji-Youn Han, Lecia V Sequist, Byoung Chul Cho, J.S. Lee, Sang-We Kim, W. Su, C. Tsai, James Chih-Hsin Yang, Helena Yu, L. Horn, K. Lee, V. Haddad, M.M. Frigault, G. Ahmed, L. Yang, D. Ghiorghiu, Geoffrey R. Oxnard
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-005 - ASTRIS: A Real World Study of Osimertinib Treatment in Patients with EGFR T790M Positive Advanced NSCLC; Interim Analysis
09:30 - 09:30 | Presenter: Sang-We Kim | Author(s): Byoung Chul Cho, D. Kim, Keunchil Park, M. Tiseo, M.R. Migliorino, A. Santo, J. Lee, D. Vicente, A. Paredes, E. O'Hanrahan, Helano Carioca Freitas, M. Provencio, Y. Chen, P.K. Cheema, A. Milner, J.R. Rigas, Yi-Long Wu, F. De Marinis
- Abstract
Loading... -
+
P3.01-050 - A Real World Treatment Study of Osimertinib: ASTRIS Study Korean Subgroup Analysis
09:30 - 09:30 | Presenter: Byoung Chul Cho | Author(s): D. Kim, Keunchil Park, J. Lee, S.S. Yoo, Jin-Hyoung Kang, Sung Yong Lee, C.H. Kim, S.H. Jang, Young-Chul Kim, H. Yoon, Sang-We Kim
- Abstract
Loading...